Why the study?
As TAVR expands to younger and lower-risk patients, the demand for post-TAVR coronary angiograms and PCIs will increase, posing potential technical challenges.
Does the presence of a balloon-expandable TAVR valve affect the technical characteristics and feasibility of subsequent coronary angiography and PCI?
Does the presence of a balloon-expandable TAVR valve affect the technical characteristics and feasibility of subsequent coronary angiography and PCI?
Coronary angiography and PCI can be performed effectively after TAVR with a balloon-expandable valve without significant technical challenges compared to pre-TAVR procedures.
Answers are grounded in this paper and cite their sources.
Post-TAVR coronary access is feasible with technical differences; leaves open optimal valve and procedural strategies for younger patients.
OBJECTIVES: To report on the feasibility and technical differences between coronary procedures performed before and after TAVR with the balloon-expandable Edwards-SAPIEN or the SAPIEN XT valves. BACKGROUND: Coronary artery disease (CAD) and aortic stenosis often coexist. Transcatheter aortic valve replacement (TAVR) is emerging as a treatment for younger and lower surgical risk patients who might not present with clinically evident CAD before TAVR. The demand for performing post-TAVR coronary angiograms (CAs) and percutaneous coronary interventions (PCIs) will thus increase, posing new technical challenges. METHODS: Over 1000 TAVRs were performed at the Quebec Heart and Lung Institute, of which 616 with the abovementioned valves. Of these, 28 patients had an analyzable pre- and post-TAVR CAs and 13 patients had pre- and post-TAVR PCIs performed. Procedural characteristics were gathered from all coronary procedures and subsequently compared amongst the same type of procedure performed at these two distinct time periods. RESULTS: Neither CAs-nor PCIs-performed after valve implantation revealed significant differences regarding arterial access site, catheter diameter, number of diagnostic or guiding catheters used, procedural duration, fluoroscopy time, or achievement of selective coronary injection. Lesion location and classification, as well as the preference of using a drug-eluting stent, remained unchanged. During post-TAVR CA, the amount of contrast delivered and the radiation dose area product were significantly lower compared with pre-TAVR CA values. CONCLUSIONS: Performance of CA and PCI after TAVR with a balloon-expandable valve appears unaffected by its presence.
No takes yet. Share an insight, caveat, or question.
Ferreira‐Neto et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: